A comprehensive evaluation of de novo metastatic breast cancer trends by subtype from the Dallas Metastatic Cancer Study.

ABSTRACT:

Background

The Dallas Metastatic Cancer Study is a clinical database established to examine local trends associated with the diagnosis and treatment of de novo metastatic breast cancer and identify factors for further evaluation. Clinical characteristics of patients with de novo metastatic breast cancer are often underreported in the literature.

Methods

We report data from 2010 to 2021 for patients with de novo metastatic breast cancer along with the impact of clinical variables such as age, BMI, race and ethnicity, insurance status, hypertension, diabetes, and site of metastasis with survival analysis with respect to subtype.

Results

Black race (HR 2.07, 95% CI 1.56-2.74), public insurance (HR 1.64, 95% CI 1.23-2.18), no insurance (HR 1.69, 95% CI 1.24-2.31), hyperte

SUBMITTER: Chang HL 

PROVIDER: S-EPMC12325588 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature